4005.T JPX
Sumitomo Chemical Company, Limited
1W: -0.6%
1M: +0.5%
3M: +11.9%
YTD: +0.9%
1Y: +43.1%
3Y: +40.8%
5Y: +12.2%
¥574.80 ($3.64)
-5.30 (-0.91%)
Weekly Expected Move ±4.8%
¥520
¥547
¥575
¥602
¥630
Overview
Chart
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ETF Exposure
Balance Sheet Trends
Total Assets
$3.41T
-1.0% ▼
5Y CAGR: -3.1%
Total Liabilities
$2.17T
-8.3% ▼
5Y CAGR: -2.9%
Shareholders Equity
$1.01T
+12.0% ▲
5Y CAGR: -0.2%
Cash & Investments
$208.6B
-0.6% ▼
5Y CAGR: -10.4%
Total Debt
$1.15T
-15.9% ▼
5Y CAGR: -3.1%
Net Debt
$942.9B
-18.7% ▼
Assets vs Liabilities & Equity
Year-over-Year Growth
View Full Balance Sheet
| Line Item | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|---|
| — Assets — | |||||
| Cash | $365.4B | $305.8B | $217.4B | $209.8B | $208.6B |
| Short-Term Investments | $24.0B | $0 | $0 | $0 | $0 |
| Cash & ST Investments | $389.4B | $305.8B | $217.4B | $209.8B | $208.6B |
| Net Receivables | $720.4B | $603.2B | $620.0B | $593.8B | $608.7B |
| Inventory | $651.4B | $744.5B | $709.6B | $625.2B | $595.5B |
| Other Current Assets | $51.4B | $109.4B | $128.8B | $154.2B | $95.0B |
| Total Current Assets | $1.81T | $1.76T | $1.68T | $1.58T | $1.51T |
| Property, Plant & Equip. | $823.0B | $829.4B | $796.5B | $759.3B | $770.7B |
| Goodwill & Intangibles | $715.6B | $670.9B | $536.7B | $497.1B | $501.0B |
| Long-Term Investments | $907.7B | $684.9B | $320.0B | $465.4B | $505.1B |
| Other Non-Current Assets | $0 | $178.1B | $568.7B | $100.3B | $81.3B |
| Total Non-Current Assets | $2.50T | $2.40T | $2.26T | $1.86T | $1.90T |
| Total Assets | $4.31T | $4.17T | $3.93T | $3.44T | $3.41T |
| — Liabilities — | |||||
| Accounts Payable | $551.6B | $515.9B | $543.4B | $488.1B | $464.4B |
| Short-Term Debt | $261.3B | $396.9B | $585.9B | $252.9B | $241.4B |
| Deferred Revenue | $238.4B | $237.5B | $0 | $0 | $0 |
| Other Current Liabilities | $97.8B | $96.3B | $305.7B | $287.1B | $288.5B |
| Total Current Liabilities | $1.17T | $1.28T | $1.44T | $1.04T | $1.00T |
| Long-Term Debt | $1.09T | $1.06T | $977.6B | $1.03T | $910.0B |
| Other Non-Current Liab. | -$14.9B | -$23.1B | $44.4B | $99.1B | $178.7B |
| Total Non-Current Liabilities | $1.43T | $1.40T | $1.33T | $1.33T | $1.17T |
| Total Liabilities | $2.61T | $2.68T | $2.77T | $2.37T | $2.17T |
| — Equity — | |||||
| Common Stock | $89.7B | $89.8B | $89.9B | $90.1B | $90.2B |
| Retained Earnings | $974.4B | $891.6B | $578.2B | $640.6B | $655.4B |
| Accumulated OCI | $135.3B | $198.2B | $305.8B | $178.5B | $263.8B |
| Total Stockholders Equity | $1.22T | $1.17T | $965.8B | $900.8B | $1.01T |
| Total Liabilities & Equity | $4.31T | $4.17T | $3.93T | $3.44T | $3.41T |
| — Key Metrics — | |||||
| Total Debt | $1.35T | $1.46T | $1.56T | $1.37T | $1.15T |
| Net Debt | $985.0B | $1.16T | $1.35T | $1.16T | $942.9B |
| Total Investments | $931.7B | $684.9B | $320.0B | $465.4B | $505.1B |